These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16826749)

  • 1. [Natural immunity and herpes infection].
    Lavrov VF; Koval'chuk LV; Gankovskaia LV; Barkevich OA; Kuzin SN
    Vopr Virusol; 2006; 51(3):4-9. PubMed ID: 16826749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herpes simplex virus-2 in the genital mucosa: insights into the mucosal host response and vaccine development.
    Lee AJ; Ashkar AA
    Curr Opin Infect Dis; 2012 Feb; 25(1):92-9. PubMed ID: 22143115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective immunity to genital herpes simplex virus type 1 and type 2 provided by self-adjuvanting lipopeptides that drive dendritic cell maturation and elicit a polarized Th1 immune response.
    Bettahi I; Zhang X; Afifi RE; BenMohamed L
    Viral Immunol; 2006; 19(2):220-36. PubMed ID: 16817765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement Opsonization Promotes Herpes Simplex Virus 2 Infection of Human Dendritic Cells.
    Crisci E; Ellegård R; Nyström S; Rondahl E; Serrander L; Bergström T; Sjöwall C; Eriksson K; Larsson M
    J Virol; 2016 May; 90(10):4939-4950. PubMed ID: 26937039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher Throughput Quantification of Neutralizing Antibody to Herpes Simplex Viruses.
    Blevins TP; Mitchell MC; Korom M; Wang H; Yu Y; Morrison LA; Belshe RB
    PLoS One; 2015; 10(12):e0144738. PubMed ID: 26658766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of intracerebral cytokine production in mice infected with herpes simplex virus types 1 and 2.
    Lewandowski G; Hobbs MV; Bloom FE
    J Neuroimmunol; 1994 Nov; 55(1):23-34. PubMed ID: 7962482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of mucosal immunity in preventing genital herpes infection.
    MasCasullo V; Fam E; Keller MJ; Herold BC
    Viral Immunol; 2005; 18(4):595-606. PubMed ID: 16359226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The primary immune response and virus-specific and -nonspecific immune complexes in neonatal cytomegalovirus and herpetic infection].
    Vel'tishcheva EIu; Viduta OD; Ponomareva AM; Karakhan NM; Nisan LG; Dement'eva NM; Aleshkin VA
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (6):104-5. PubMed ID: 8079522
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of a novel serology algorithm to detect herpes simplex virus 1 or 2 antibodies.
    Zahariadis G; Severini A
    Sex Transm Dis; 2010 Nov; 37(11):696-9. PubMed ID: 20693937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A killed commercial vaccine against herpes simplex viruses 1 and 2 as an immunocorrective agent in chronic herpetic infection].
    Barinskiĭ IF; Kasparov AA; Lazarenko AA; Alimbarova LM; Davydova AA; Belkina IV; Platonova AL
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (6):98-102. PubMed ID: 10876868
    [No Abstract]   [Full Text] [Related]  

  • 11. Highly Efficacious Novel Vaccine, Humoral Immunity, and Ocular Herpes Simplex Virus 1: Reality or Myth?
    Ghiasi H
    J Virol; 2017 Dec; 91(23):. PubMed ID: 29138327
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunologic assessment of neonatal herpes simplex virus infection in one dizygotic twin.
    Plaeger-Marshall S; Lewis K; Sullivan-Bolyai J; Bryson YJ
    Pediatr Infect Dis J; 1989 Mar; 8(3):171-5. PubMed ID: 2469058
    [No Abstract]   [Full Text] [Related]  

  • 13. On the role of endogenous interferon in natural and induced antiviral resistance.
    Kirchner H; Zawatzky R; Storch E; Domke I; Chmielarczyk W
    Antiviral Res; 1985; Suppl 1():155-9. PubMed ID: 2417549
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of dendritic cells in immune responses against vaginal infection by herpes simplex virus type 2.
    Iwasaki A
    Microbes Infect; 2003 Nov; 5(13):1221-30. PubMed ID: 14623018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NKT cell activation by local α-galactosylceramide administration decreases susceptibility to HSV-2 infection.
    Iversen MB; Jensen SK; Hansen AL; Winther H; Issazadeh-Navikas S; Reinert LS; Holm CK
    Immunobiology; 2015 Jun; 220(6):762-8. PubMed ID: 25648689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Host immune response to herpes simplex virus infection].
    Hayashi K
    Uirusu; 1989 Jun; 39(1):1-19. PubMed ID: 2481368
    [No Abstract]   [Full Text] [Related]  

  • 17. Dancing with the enemy: the interplay of herpes simplex virus with dendritic cells.
    Novak N; Peng WM
    Clin Exp Immunol; 2005 Dec; 142(3):405-10. PubMed ID: 16297150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herpes simplex virus antigens directly activate NK cells via TLR2, thus facilitating their presentation to CD4 T lymphocytes.
    Kim M; Osborne NR; Zeng W; Donaghy H; McKinnon K; Jackson DC; Cunningham AL
    J Immunol; 2012 May; 188(9):4158-70. PubMed ID: 22467654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serological testing for herpes simplex virus (HSV)-1 and HSV-2 infection.
    Wald A; Ashley-Morrow R
    Clin Infect Dis; 2002 Oct; 35(Suppl 2):S173-82. PubMed ID: 12353203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innate immunity to herpes simplex virus type 2.
    Duerst RJ; Morrison LA
    Viral Immunol; 2003; 16(4):475-90. PubMed ID: 14733735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.